93
Participants
Start Date
May 31, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
Afamelanotide
One 16mg subcutaneous implant every 2 months for 6 months.
Placebo
One placebo subcutaneous implant every 2 months for 6 months
Mt. Sinai, New York
Carolina's Medical Center Cannon Research, Charlotte
University of Alabama, Birmingham
Henry Ford Medical Center, Detroit
University of Texas, Galveston
University of Utah, Salt Lake City
University of California, San Francisco, San Francisco
Lead Sponsor
Clinuvel Pharmaceuticals Limited
INDUSTRY